| 1 | Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients | 2.8 | 15 | Citations (PDF) |
| 2 | Pediatric migraine care: bridging gaps, overcoming barriers, and advancing solutions | 1.6 | 13 | Citations (PDF) |
| 3 | Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache | 2.8 | 8 | Citations (PDF) |
| 4 | Treatment of migraine with fremanezumab and sleep: A preliminary case series | 0.6 | 1 | Citations (PDF) |
| 5 | Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.Brain, 2024, 147, 1312-1320 | 6.0 | 22 | Citations (PDF) |
| 6 | Novel insight into atogepant mechanisms of action in migraine prevention.Brain, 2024, 147, 2884-2896 | 6.0 | 34 | Citations (PDF) |
| 7 | Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling | 4.3 | 7 | Citations (PDF) |
| 8 | Hypersensitivity to BKCa channel opening in persistent post-traumatic headache | 4.3 | 8 | Citations (PDF) |
| 9 | The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group | 1.9 | 26 | Citations (PDF) |
| 10 | Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management | 18.0 | 16 | Citations (PDF) |
| 11 | Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action | 2.8 | 79 | Citations (PDF) |
| 12 | Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats | 2.8 | 7 | Citations (PDF) |
| 13 | International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine | 2.8 | 119 | Citations (PDF) |
| 14 | Pain sensitivity in relation to frequency of migraine and tension-type headache with or without coexistent neck pain: an exploratory secondary analysis of the population study | 1.0 | 20 | Citations (PDF) |
| 15 | Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: A prospective quantitative sensory testing study (NCT04271202) | 2.8 | 37 | Citations (PDF) |
| 16 | Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders | 4.3 | 35 | Citations (PDF) |
| 17 | Neck pain and headache: Pathophysiology, treatments and future directions | 1.1 | 35 | Citations (PDF) |
| 18 | Hippocampal volume changes across developmental periods in female migraineurs | 1.6 | 2 | Citations (PDF) |
| 19 | Galcanezumab effects on incidence of headache after occurrence of triggers, prodromes, and aura in responders, non-responders, super-responders and super non-responders (P12-12.012) | 0.7 | 0 | Citations (PDF) |
| 20 | Botox (onabotulinumtoxinA) mechanism of action | 1.0 | 63 | Citations (PDF) |
| 21 | Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diary | 1.6 | 17 | Citations (PDF) |
| 22 | Peripherally acting anti-CGRP monoclonal antibodies alter cortical gray matter thickness in migraine patients: A prospective cohort study | 2.2 | 25 | Citations (PDF) |
| 23 | Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache | 2.8 | 11 | Citations (PDF) |
| 24 | Migraine | 39.8 | 468 | Citations (PDF) |
| 25 | FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine | 2.8 | 19 | Citations (PDF) |
| 26 | Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD | 2.8 | 34 | Citations (PDF) |
| 27 | OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patientsBrain, 2022, 145, 2436-2449 | 6.0 | 31 | Citations (PDF) |
| 28 | Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain | 0.7 | 24 | Citations (PDF) |
| 29 | Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by Cortical Spreading Depression (CSD) (S31.003) | 0.7 | 0 | Citations (PDF) |
| 30 | Psychotherapeutic approach for the treatment of generalized anxiety disorder (GAD) improves outcome when delivered under specific (narrow band) green light condition. (P5-12.004) | 0.7 | 0 | Citations (PDF) |
| 31 | Exposure to narrow band green light (nbGL) reduces migraineous headache and photophobia: Large open-label study conducted online using daily headache diary (P7-2.003) | 0.7 | 0 | Citations (PDF) |
| 32 | Altered Brain Network Connectivity Underlies Persistent Post-Traumatic Headache following Mild Traumatic Brain Injury in Youth | 2.4 | 17 | Citations (PDF) |
| 33 | Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons | 2.8 | 43 | Citations (PDF) |
| 34 | Adverse effects of erenumab on cerebral proliferative angiopathy: A case report | 2.8 | 18 | Citations (PDF) |
| 35 | Ictal and interictal brain activation in episodic migraine: Neural basis for extent of allodynia | 1.5 | 39 | Citations (PDF) |
| 36 | OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier : PAIN | 3.0 | 4 | Citations (PDF) |
| 37 | Efficacy of erenumab in chronic migraine patients with and without ictal allodynia | 2.8 | 15 | Citations (PDF) |
| 38 | Mapping migraine to a common brain network.Brain, 2020, 143, 541-553 | 6.0 | 97 | Citations (PDF) |
| 39 | Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier | 2.8 | 97 | Citations (PDF) |
| 40 | Nightly sleep duration, fragmentation, and quality and daily risk of migraine | 0.7 | 60 | Citations (PDF) |
| 41 | Celecoxib reduces cortical spreading depression–induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in terminating migraine attacks : PAIN | 3.0 | 17 | Citations (PDF) |
| 42 | Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood–brain barrier : PAIN | 3.0 | 40 | Citations (PDF) |
| 43 | Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysis | 2.8 | 27 | Citations (PDF) |
| 44 | Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale? | 1.9 | 90 | Citations (PDF) |
| 45 | Activation of Peripheral and Central Trigeminovascular Neurons by Seizure: Implications for Ictal and Postictal Headache | 2.3 | 9 | Citations (PDF) |
| 46 | Unrecognized challenges of treating status migrainosus: An observational study | 2.8 | 19 | Citations (PDF) |
| 47 | Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review | 1.9 | 196 | Citations (PDF) |
| 48 | Ubrogepant is Effective in the Acute Treatment of Migraine with Mild Pain (4726) | 0.7 | 3 | Citations (PDF) |
| 49 | Extracranial Injections of OnabotulinumtoxinA in Combination with Intravenous Injection of Atogepant Attenuates Activation and Sensitization of HT and WDR Neurons by CSD (4287) | 0.7 | 0 | Citations (PDF) |
| 50 | The association between migraine and hospital readmission due to pain after surgery: A hospital registry study | 2.8 | 15 | Citations (PDF) |
| 51 | Current understanding of photophobia, visual networks and headaches | 2.8 | 111 | Citations (PDF) |
| 52 | Emerging evidence of occipital nerve compression in unremitting head and neck pain | 4.3 | 59 | Citations (PDF) |
| 53 | Headache in Petrous Apicitis: A Case Report of Chronic Migraine-like Headache Due to Peripheral Pathology | 1.9 | 6 | Citations (PDF) |
| 54 | Hypothalamic regulation of headache and migraine | 2.8 | 148 | Citations (PDF) |
| 55 | Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats. | 2.8 | 43 | Citations (PDF) |
| 56 | CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura | 2.3 | 74 | Citations (PDF) |
| 57 | Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial | 1.9 | 149 | Citations (PDF) |
| 58 | People also looked at | 1.7 | 19 | Citations (PDF) |
| 59 | The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory | 3.0 | 36 | Citations (PDF) |
| 60 | Neurobiology of Photophobia | 0.8 | 56 | Citations (PDF) |
| 61 | Modulation of brain networks by sumatriptan-naproxen in the inflammatory soup migraine model : PAIN | 3.0 | 10 | Citations (PDF) |
| 62 | Non-Trigeminal Nociceptive Innervation of the Posterior Dura: Implications to Occipital Headache | 2.3 | 83 | Citations (PDF) |
| 63 | Activation of pial and dural macrophages and dendritic cells by cortical spreading depression | 4.7 | 98 | Citations (PDF) |
| 64 | People also looked at | 1.6 | 48 | Citations (PDF) |
| 65 | Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls | 3.0 | 45 | Citations (PDF) |
| 66 | Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial | 1.9 | 0 | Citations (PDF) |
| 67 | Brain network alterations in the inflammatory soup animal model of migraine | 1.9 | 40 | Citations (PDF) |
| 68 | Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache | 2.3 | 238 | Citations (PDF) |
| 69 | Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache | 1.9 | 71 | Citations (PDF) |
| 70 | Extracranial origin of headache | 2.4 | 67 | Citations (PDF) |
| 71 | In child and adult migraineurs the somatosensory cortex stands out … again: An arterial spin labeling investigation. | 2.3 | 32 | Citations (PDF) |
| 72 | Fremanezumab—A Humanized Monoclonal Anti-CGRP Antibody—Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors | 2.3 | 187 | Citations (PDF) |
| 73 | Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody | 2.3 | 160 | Citations (PDF) |
| 74 | Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine | 5.3 | 70 | Citations (PDF) |
| 75 | Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study | 1.9 | 64 | Citations (PDF) |
| 76 | Statin and Vitamin D for Prevention of Migraine (S52.006) | 0.7 | 0 | Citations (PDF) |
| 77 | Green light alleviates migraine photophobia (S47.005) | 0.7 | 4 | Citations (PDF) |
| 78 | Cortico-Cortical Connections of Primary Sensory Areas and Associated Symptoms in Migraine.ENeuro, 2016, 3, ENEURO.0163-16.2016 | 1.2 | 46 | Citations (PDF) |
| 79 | People also looked at | 1.7 | 64 | Citations (PDF) |
| 80 | People also looked at | 1.7 | 55 | Citations (PDF) |
| 81 | Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache | 4.7 | 89 | Citations (PDF) |
| 82 | Migraine photophobia originating in cone-driven retinal pathways.Brain, 2016, 139, 1971-86 | 6.0 | 172 | Citations (PDF) |
| 83 | Increased Amplitude of Thalamocortical Low-Frequency Oscillations in Patients with Migraine | 2.3 | 96 | Citations (PDF) |
| 84 | Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle? | 2.8 | 131 | Citations (PDF) |
| 85 | The Insula: A “Hub of Activity” in Migraine | 2.9 | 143 | Citations (PDF) |
| 86 | Female migraineurs show lack of insular thinning with age | 3.0 | 45 | Citations (PDF) |
| 87 | The migraine brain in transition | 3.0 | 67 | Citations (PDF) |
| 88 | Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial | 4.7 | 114 | Citations (PDF) |
| 89 | Primary Somatosensory Cortices Contain Altered Patterns of Regional Cerebral Blood Flow in the Interictal Phase of Migraine | 1.5 | 46 | Citations (PDF) |
| 90 | A new electronic diary tool for mapping and tracking spatial and temporal head pain patterns in migraine | 2.8 | 18 | Citations (PDF) |
| 91 | Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study | 24.0 | 249 | Citations (PDF) |
| 92 | Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study | 24.0 | 269 | Citations (PDF) |
| 93 | Association of statin use and risk for severe headache or migraine by serum vitamin D status: A cross-sectional population-based study | 2.8 | 37 | Citations (PDF) |
| 94 | Altered Hypothalamic Functional Connectivity with Autonomic Circuits and the Locus Coeruleus in Migraine | 1.5 | 136 | Citations (PDF) |
| 95 | Neurochemical Pathways That Converge on Thalamic Trigeminovascular Neurons: Potential Substrate for Modulation of Migraine by Sleep, Food Intake, Stress and Anxiety | 1.5 | 95 | Citations (PDF) |
| 96 | Migraine Mistakes: Error Awareness | 2.9 | 18 | Citations (PDF) |
| 97 | Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains | 2.8 | 223 | Citations (PDF) |
| 98 | Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks | 8.7 | 371 | Citations (PDF) |
| 99 | Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain | 3.0 | 811 | Citations (PDF) |
| 100 | Ezogabine (KCNQ2/3 channel opener) prevents delayed activation of meningeal nociceptors if given before but not after the occurrence of cortical spreading depression | 1.4 | 13 | Citations (PDF) |
| 101 | Concurrent functional and structural cortical alterations in migraine | 2.8 | 200 | Citations (PDF) |
| 102 | Activation of the migraine pain pathway by cortical spreading depression: Do we need more evidence? | 2.8 | 15 | Citations (PDF) |
| 103 | Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors | 2.8 | 75 | Citations (PDF) |
| 104 | Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity | 3.5 | 92 | Citations (PDF) |
| 105 | Her versus his migraine: multiple sex differences in brain function and structure.Brain, 2012, 135, 2546-59 | 6.0 | 229 | Citations (PDF) |
| 106 | Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: implications for photophobia. | 2.3 | 77 | Citations (PDF) |
| 107 | Common hippocampal structural and functional changes in migraine | 1.6 | 163 | Citations (PDF) |
| 108 | Log in to my account | 0.6 | 83 | Citations (PDF) |
| 109 | Advances in understanding the mechanisms of migraine-type photophobia | 2.4 | 112 | Citations (PDF) |
| 110 | Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions | 3.0 | 134 | Citations (PDF) |
| 111 | Migraine attacks the Basal Ganglia. | 2.0 | 152 | Citations (PDF) |
| 112 | Activation of central trigeminovascular neurons by cortical spreading depression | 4.7 | 378 | Citations (PDF) |
| 113 | Cortical Projections of Functionally Identified Thalamic Trigeminovascular Neurons: Implications for Migraine Headache and Its Associated Symptoms | 2.3 | 201 | Citations (PDF) |
| 114 | Predicting Migraine Responsiveness to Botulinum Toxin Type A Injections | 1.5 | 22 | Citations (PDF) |
| 115 | Thalamic sensitization transforms localized pain into widespread allodynia | 4.7 | 391 | Citations (PDF) |
| 116 | Implanted Auriculotemporal Nerve Stimulator for the Treatment of Refractory Chronic Migraine | 1.9 | 26 | Citations (PDF) |
| 117 | A neural mechanism for exacerbation of headache by light | 11.5 | 545 | Citations (PDF) |
| 118 | Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura | 2.3 | 405 | Citations (PDF) |
| 119 | Sensory innervation of the calvarial bones of the mouse | 1.3 | 197 | Citations (PDF) |
| 120 | Almotriptan Efficacy in Migraine With Developing Allodynia Is as High as the Efficacy in Migraine Without Allodynia – But Is It the Same in Migraine With Established Allodynia? | 1.9 | 3 | Citations (PDF) |
| 121 | Revisiting the Efficacy of Sumatriptan Therapy During the Aura Phase of Migraine | 1.9 | 46 | Citations (PDF) |
| 122 | A Critical View on the Role of Migraine Triggers in the Genesis of Migraine Pain | 1.9 | 70 | Citations (PDF) |
| 123 | Migraine prophylaxis with botulinum toxin A is associated with perception of headache | 1.2 | 25 | Citations (PDF) |
| 124 | Localization of COX-1 and COX-2 in the intracranial dura mater of the rat | 1.3 | 21 | Citations (PDF) |
| 125 | Excitatory Neurotransmitters in Brain Regions in Interictal Migraine Patients | 2.0 | 87 | Citations (PDF) |
| 126 | Cutaneous allodynia in the migraine population | 4.7 | 560 | Citations (PDF) |
| 127 | Sensitization of meningeal nociceptors: inhibition by naproxen | 1.7 | 59 | Citations (PDF) |
| 128 | Prevalence and characteristics of allodynia in headache sufferersA population study | 0.7 | 359 | Citations (PDF) |
| 129 | Interictal Dysfunction of a Brainstem Descending Modulatory Center in Migraine Patients | 1.5 | 211 | Citations (PDF) |
| 130 | Sensitization and Activation of Intracranial Meningeal Nociceptors by Mast Cell Mediators | 2.3 | 160 | Citations (PDF) |
| 131 | Mast cell degranulation activates a pain pathway underlying migraine headache | 3.0 | 353 | Citations (PDF) |
| 132 | Identifying Cutaneous Allodynia in Chronic Migraine Using a Practical Clinical Method | 2.8 | 80 | Citations (PDF) |
| 133 | Improved Identification of Allodynic Migraine Patients Using a Questionnaire | 2.8 | 84 | Citations (PDF) |
| 134 | Explodingvs.imploding headache in migraine prophylaxis with Botulinum Toxin A | 3.0 | 143 | Citations (PDF) |
| 135 | Mast Cell Involvement in the Pathophysiology of Migraine Headache: A Hypothesis | 1.9 | 65 | Citations (PDF) |
| 136 | Functional Imaging of the Trigeminal System: Applications to Migraine Pathophysiology | 1.9 | 44 | Citations (PDF) |
| 137 | Terminating Migraine With Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors | 1.9 | 187 | Citations (PDF) |
| 138 | Unitary hypothesis for multiple triggers of the pain and strain of migraine | 1.3 | 206 | Citations (PDF) |
| 139 | Calcitonin gene–related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine | 4.7 | 207 | Citations (PDF) |
| 140 | Can allodynic migraine patients be identified interictally using a questionnaire? | 0.7 | 140 | Citations (PDF) |
| 141 | Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors | 3.0 | 47 | Citations (PDF) |
| 142 | Implications of multimechanism therapyWhen to treat? | 0.7 | 24 | Citations (PDF) |
| 143 | Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT1B/1D receptor agonists | 5.3 | 257 | Citations (PDF) |
| 144 | Migraine, Sensitization of Trigeminovascular Neurons, and Triptan Therapy | 0.4 | 2 | Citations (PDF) |
| 145 | Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization | 4.7 | 352 | Citations (PDF) |
| 146 | Defeating migraine pain with triptans: A race against the development of cutaneous allodynia | 4.7 | 611 | Citations (PDF) |
| 147 | Functional imaging of the human trigeminal system: Opportunities for new insights into pain processing in health and disease | 3.4 | 84 | Citations (PDF) |
| 148 | 2003 Wolff Award: Possible Parasympathetic Contributions to Peripheral and Central Sensitization During Migraine | 1.9 | 167 | Citations (PDF) |
| 149 | Deconstructing migraine headache into peripheral and central sensitization | 3.0 | 338 | Citations (PDF) |
| 150 | A neurohistochemical blueprint for pain-induced loss of appetite | 5.3 | 133 | Citations (PDF) |
| 151 | An association between migraine and cutaneous allodynia | 4.7 | 976 | Citations (PDF) |
| 152 | Trigeminohypothalamic and Reticulohypothalamic Tract Neurons in the Upper Cervical Spinal Cord and Caudal Medulla of the Rat | 1.4 | 264 | Citations (PDF) |
| 153 | The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.Brain, 2000, 123 ( Pt 8), 1703-9 | 6.0 | 712 | Citations (PDF) |
| 154 | Cardiovascular and Neuronal Responses to Head Stimulation Reflect Central Sensitization and Cutaneous Allodynia in a Rat Model of Migraine | 1.4 | 85 | Citations (PDF) |
| 155 | Cells of origin of the trigeminohypothalamic tract in the rat | 1.3 | 137 | Citations (PDF) |
| 156 | Chemical Stimulation of the Intracranial Dura Induces Enhanced Responses to Facial Stimulation in Brain Stem Trigeminal Neurons | 1.4 | 579 | Citations (PDF) |
| 157 | Distinct lateral and medial projections of the spinohypothalamic tract of the rat | 1.3 | 46 | Citations (PDF) |
| 158 | Sensitization of meningeal sensory neurons and the origin of headaches | 31.8 | 679 | Citations (PDF) |
| 159 | Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla | 1.4 | 263 | Citations (PDF) |
| 160 | Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat | 1.3 | 137 | Citations (PDF) |
| 161 | Fos-like immunoreactivity in the superficial medullary dorsal horn induced by noxious and innocuous thermal stimulation of facial skin in the rat | 1.4 | 81 | Citations (PDF) |
| 162 | The cells of origin of the spinohypothalamic tract in cats | 1.3 | 47 | Citations (PDF) |
| 163 | Cells of origin of the spinohypothalamic tract in the rat | 1.3 | 204 | Citations (PDF) |
| 164 | The cells of origin of the spinothalamic tract of the rat: a quantitative reexamination | 1.9 | 159 | Citations (PDF) |
| 165 | Neurons in the sacral parasympathetic nucleus that project to the hypothalamus do not also project through the pelvic nerve—a double labeling study combining Fluoro-gold and cholera toxin B in the rat | 1.9 | 30 | Citations (PDF) |
| 166 | Evidence that Fluoro-Gold can be transported avidly through fibers of passage | 1.9 | 108 | Citations (PDF) |
| 167 | Retrograde labeling of neurons in spinal cord that project directly to nucleus accumbens or the septal nuclei in the rat | 1.9 | 96 | Citations (PDF) |
| 168 | Activated Adsorption and Para-Ortho Hydrogen Conversion on Charcoal | 31.8 | 2 | Citations (PDF) |
| 169 | Calcitonin Gene-Related Peptide (CGRP)-Expressing Neurons in the External Lateral Parabrachial Area Regulate Pain-Induced Sleep Disturbances | 7.8 | 4 | Citations (PDF) |
| 170 | Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache Open Access | 6.0 | 8 | Citations (PDF) |
| 171 | OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female mice | 2.8 | 4 | Citations (PDF) |
| 172 | Mapping Dural and Periosteal SV2C, a Botulinum Toxin A Receptor, in the Mouse | 2.5 | 0 | Citations (PDF) |
| 173 | Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society | 2.8 | 21 | Citations (PDF) |
| 174 | Elucidating the nociceptive role of CGRP in migraine headache Open Access | 6.0 | 5 | Citations (PDF) |
| 175 | Migraine as a primary care-sensitive condition: Building pathways to accessible care. | 2.8 | 2 | Citations (PDF) |
| 176 | Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society. | 2.8 | 2 | Citations (PDF) |
| 177 | Healthcare providers' perspectives on headache care in Azerbaijan: results of a national cross-sectional survey. | 1.6 | 0 | Citations (PDF) |
| 178 | Establishing a core curriculum in headache medicine: Best practices from the international headache society education committee. | 2.8 | 0 | Citations (PDF) |
